A 194-year-old tortoise and a question about aging
Jonathan, a giant tortoise living on St. Helena, is 194 years old. His exceptional lifespan has made him more than a historical curiosity: researchers are using his biology to explore why some animals preserve health for so long.
An international collaboration led by a neurologist and advanced-genomics specialists at Vanderbilt Health has assembled Jonathan’s genome and identified a feature the team links to his unusually resilient aging. The findings were published October 7 in Science Advances.
The study focuses on mitochondrial energy production. Mitochondria are the structures in most animal cells that produce energy needed for many biological functions. Their decline is widely considered a hallmark of aging, and the researchers’ account of Jonathan suggests that preserving the regulation of mitochondrial genes may be one route to maintaining health across an extraordinary lifespan.
Entropy at the genetic control switches
The key idea is entropy: the tendency of biological systems to become more disordered with time. In this case, the researchers examined promoters, the genetic on-and-off switches that help regulate the activity of genes.
As organisms age, increasing disorder in promoters can affect the efficiency of mitochondria. When the regulation of energy-producing genes becomes less orderly, cells may struggle to maintain the reliable energy supply required for normal processes.
Jonathan appears to have avoided much of that decline. By piecing together his genome, the researchers found that promoters associated with genes involved in mitochondrial energy production retained a notably youthful degree of orderliness. In that respect, the study indicates that his genetic regulation resembled that of a much younger animal.
This is not a claim that Jonathan has stopped aging, nor does it establish a treatment for people. It is a clue from an exceptionally long-lived animal. But it gives researchers a more specific biological target than longevity studies often provide: the preservation of orderly gene regulation around the machinery that supplies cellular energy.
Why mitochondrial function is central
Cells rely on energy continuously. Mitochondria help supply it, and their performance affects a wide range of processes across the body. The study’s emphasis on promoter orderliness links aging not simply to damaged components, but also to the instructions that govern how important cellular systems operate.
That distinction matters. A cell can contain the genes needed to support energy production, yet changes in genetic regulation can alter how effectively those genes are used. If aging is accompanied by increasing disorder in those regulatory switches, then protecting their organization may help preserve mitochondrial function.
Jonathan’s genome offers a natural experiment spanning nearly two centuries. Animals with exceptional lifespans can reveal patterns that may be difficult to detect in shorter-lived species. The tortoise’s durability does not automatically translate to humans, whose biology and environment differ substantially. Still, it can help scientists frame new questions about which aging processes are fundamental and which are potentially modifiable.
From an animal finding to human healthspan research
The researchers say the findings suggest it may be possible to protect mitochondria from the aging-related effects of disordered gene expression. The goal is not merely longer life, but a longer healthspan: more years spent in relatively good health.
That framing is especially important for aging research. Extending lifespan without preserving function would not necessarily improve life for most people. A healthspan approach asks whether biological interventions can delay the loss of cellular resilience that contributes to age-related decline.
Stephen “Wes” Clark, the study’s senior and corresponding author, is also president and chief scientist of the Kallel Foundation, a Nashville nonprofit focused on longevity research. Clark pointed to previous animal work suggesting anti-aging potential for certain generic medicines, including rapamycin, originally developed in 1999 to prevent rejection of transplanted organs.
Generic drugs pose a practical challenge for this field. Because they no longer have patent protection, pharmaceutical companies may have limited commercial incentive to fund the clinical trials needed to determine whether a promising finding can benefit people. Clark said the foundation was established in part to work around that bottleneck by supporting trials that drug companies may not pursue.
What the finding does and does not show
The Jonathan study identifies an association in a remarkable individual and points to a biological mechanism worth investigating. It does not show that changing promoter orderliness in people will reproduce the tortoise’s longevity, and it does not establish that any particular drug can safely extend human healthspan.
Those questions require carefully designed human clinical trials. Researchers would need to determine whether an intervention can affect the relevant genetic and mitochondrial processes, whether the effect is durable, and whether it produces meaningful health benefits without unacceptable risks.
The study also reinforces the value of genomics in comparative aging research. Understanding why an unusually long-lived animal remains biologically robust can provide hypotheses that conventional studies might miss. Rather than treating exceptional lifespan as an isolated curiosity, scientists can use it to investigate mechanisms that may be conserved across species.
An unusually useful animal model
Jonathan’s value to science lies partly in the contrast between his chronological age and the youthful orderliness observed in the mitochondrial gene promoters examined by the team. Aging is often described as an accumulation of failures. His genome offers evidence that at least one important regulatory layer may have remained comparatively well organized.
That observation will not immediately change medicine. Its importance is that it directs attention to a concrete link between gene regulation, mitochondrial performance and healthy aging. If future research can show how that orderliness is preserved, and whether it can be supported in humans, Jonathan may contribute a lasting insight far beyond the island where he lives.
This article is based on reporting by Medical Xpress. Read the original article.
Originally published on medicalxpress.com
